David Eidelberg
Chief Financial Officer
pharmaceutical sciences
ovd therapeutics
Netherlands
Biography
David Eidelberg, M.D. is internationally recognized for his pioneering work using functional brain networks as biomarkers of neurological disease. Using PET and fMRI, he and his colleagues have identified and validated specific network biomarkers for Parkinson’s disease, Huntington’s disease, dystonia and Tourette syndrome, as well as cognitive disorders such as Alzheimer’s disease and fronto-temporal dementia. His work has led to accurate network-based algorithms for early diagnosis and assessment of disease progression in individuals with these disorders. Dr. Eidelberg received his medical degree from Harvard Medical School. After completing residency training in neurology at Harvard, he pursued postdoctoral training in brain imaging with MRI (National Hospital, London) and PET (Cornell, New York). He has led the Center for Neurosciences at The Feinstein Institute for Medical Research since its founding in 2001, serving as director and Susan and Leonard Feinstein professor of neurology and neuroscience. Since 1995, Dr. Eidelberg has received over $15 million in research support from the NIH and other prominent funding agencies. He is the author of over 350 peer-reviewed research articles, editorials and reviews, as well as a textbook (Brain Imaging in Parkinson’s Disease, Oxford University Press 2011). He serves on the editorial boards of several high-impact journals in the neurology, neuroscience and brain imaging space, and is a scientific advisor to the Michael J. Fox Foundation, the Department of Defense, and the COBRE Center for Neurodegeneration and Translational Neuroscience (CNTN).
Research Interest